We are live on
!
Find out more
Cooke & Bieler Portfolio holdings
AUM
$8.65B
Turnover
8.49%
1-Year Est. Return
9.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.25%
1 Year Est. Return
+9.66%
3 Year Est. Return
+36.96%
5 Year Est. Return
+35.44%
10 Year Est. Return
+164.48%
AUM
$5.87B
AUM Growth
+$149M
(+2.6%)
Cap. Flow
+$32M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
103
New
5
Increased
36
Reduced
52
Closed
5
Avg Time Held
3.5
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles Schwab
SCHW
|
+$65.7M |
| 2 |
HCA Healthcare
HCA
|
+$57.2M |
| 3 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$53.9M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$51.3M |
| 5 |
BWX Technologies
BWXT
|
+$27.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.4M |
| 2 |
World Kinect Corp
WKC
|
+$50.7M |
| 3 |
Intercontinental Exchange
ICE
|
+$37M |
| 4 |
Johnson Controls International
JCI
|
+$27.4M |
| 5 |
Applied Materials
AMAT
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.98% |
| 2 | Industrials | 17.91% |
| 3 | Healthcare | 14.91% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Technology | 11.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Medtronic
MDT
$121B
| $92.4M | 1.57% |
850,328
-118,625
| -12% | -$12.4M |
2019 Q2
1 quarter
|
|
27
Whirlpool
WHR
$1.82B
| $92.2M | 1.57% |
582,415
-2,798
| -0.5% | -$402K |
2015 Q4
15 quarters
|
|
28
Labcorp
LH
$25.8B
| $91.8M | 1.56% |
635,927
-3,757
| -0.6% | -$548K |
2014 Q1
22 quarters
|
|
29
ExxonMobil
XOM
$736B
| $91.1M | 1.55% |
1,290,307
-14,054
| -1% | -$1.02M |
2013 Q2
25 quarters
|
|
30
Johnson & Johnson
JNJ
$616B
| $90.1M | 1.54% |
696,527
-1,919
| -0.3% | -$253K |
2013 Q2
25 quarters
|
|
31
Ametek
AME
$56.9B
| $89.9M | 1.53% |
979,044
-21,391
| -2% | -$1.89M |
2016 Q3
12 quarters
|
|
32
3M
MMM
$85B
| $85.2M | 1.45% |
620,058
+159,121
| +35% | +$22.2M |
2018 Q3
4 quarters
|
|
33
UnitedHealth
UNH
$360B
| $84.9M | 1.45% |
390,837
+9,290
| +2% | +$2.24M |
2013 Q2
25 quarters
|
|
34
CBRE Group
CBRE
$38.5B
| $82.9M | 1.41% |
1,564,089
-9,189
| -0.6% | -$483K |
2016 Q3
12 quarters
|
|
35
Helen of Troy
HELE
$678M
| $81.5M | 1.39% |
516,760
-27,255
| -5% | -$4.05M |
2013 Q3
24 quarters
|
|
|
36
Intercontinental Exchange
ICE
$90.7B
| $77.7M | 1.32% |
841,921
-405,433
| -33% | -$37M |
2017 Q1
10 quarters
|
|
37
Axalta
AXTA
$7.16B
| $73.5M | 1.25% |
2,438,937
-535,710
| -18% | -$15.8M |
2016 Q1
14 quarters
|
|
38
Winnebago Industries
WGO
$678M
| $71.2M | 1.21% |
1,855,847
-29,821
| -2% | -$1.09M |
2013 Q2
25 quarters
|
|
|
AGN
39
DELISTED
Allergan plc
AGN
| $71.1M | 1.21% |
422,520
-315,538
| -43% | -$51.4M |
2016 Q4
11 quarters
|
|
40
PNC Financial Services
PNC
$86.7B
| $70M | 1.19% |
499,251
-3,662
| -0.7% | -$497K |
2013 Q2
25 quarters
|
|
41
Becton Dickinson
BDX
$52.2B
| $69.7M | 1.19% |
282,236
+15,259
| +6% | +$3.77M |
2013 Q2
25 quarters
|
|
42
Mativ Holdings
MATV
$619M
| $69.2M | 1.18% |
1,849,040
-182,525
| -9% | -$6.29M |
2013 Q2
25 quarters
|
|
|
43
Charles Schwab
SCHW
$159B
| $68.1M | 1.16% |
+1,628,731
| New | +$65.7M |
2019 Q3
0 quarters
|
|
|
44
Johnson Controls International
JCI
$88.1B
| $68.1M | 1.16% |
1,550,739
-646,106
| -29% | -$27.4M |
2017 Q4
7 quarters
|
|
45
Philip Morris
PM
$320B
| $67.9M | 1.16% |
894,378
-13,690
| -2% | -$1.08M |
2013 Q2
25 quarters
|
|
46
DELISTED
Steelcase
SCS
| $65.2M | 1.11% |
3,546,090
-33,380
| -0.9% | -$555K |
2013 Q2
25 quarters
|
|
|
47
Applied Materials
AMAT
$325B
| $54.2M | 0.92% |
1,085,995
-451,503
| -29% | -$21.8M |
2018 Q3
4 quarters
|
|
|
48
HCA Healthcare
HCA
$99.3B
| $53.3M | 0.91% |
+442,314
| New | +$57.2M |
2019 Q3
0 quarters
|
|
|
SYNH
49
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $52.8M | 0.9% |
993,204
-17,340
| -2% | -$890K |
2017 Q2
9 quarters
|
|
|
TCF
50
DELISTED
TCF Financial Corporation Common Stock
TCF
| $51.6M | 0.88% |
+1,356,266
| New | +$53.9M |
2019 Q3
0 quarters
|
|
Similar funds
GA
Cooke & Bieler's Q3 2019 Portfolio in Review
As of Q3 2019, Cooke & Bieler held 103 positions worth $5.87B, up 2.6% from $5.72B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Cooke & Bieler's Q3 2019 filing shows 5 new, 36 increased, 52 reduced and 5 closed positions. Its largest new stake was Charles Schwab: 1,628,731 shares worth $68.1M. The largest sale was Allergan plc, an estimated $51.4M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
- Cooke & Bieler's largest Q3 2019 buy was Charles Schwab: 1,628,731 shares worth $68.1M.
- Cooke & Bieler added most to Activision Blizzard in Q3 2019, an estimated $51.3M increase.
- Cooke & Bieler's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $51.4M.
- Cooke & Bieler fully exited World Kinect Corp in Q3 2019, selling an estimated $50.7M.
- Cooke & Bieler's ten largest holdings make up 23% of its $5.87B portfolio in Q3 2019.
- Cooke & Bieler opened 5 new positions and closed 5 in Q3 2019.
- Cooke & Bieler's portfolio value rose 2.6% quarter-over-quarter to $5.87B.
Based on Cooke & Bieler's 13F filing for Q3 2019, filed 7 Nov 2019.